CVRX · NASDAQ · Medical - Devices

CVRx (CVRX)

Implantable Barostim therapy improves symptoms for eligible heart-failure patients.

$3.10
Pre-market+0.03 (+0.98%)
At close$3.07(+0.99%)

Something off on this page? Send us feedback.

Next report
Nov 4, 2026
in 62 days
EPS estimate
−$0.49
Revenue estimate
$13.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.43−$0.53−$0.57−$0.49−$0.46−$0.50−$0.53Pending
Estimate−$0.37−$0.56−$0.52−$0.50−$0.42−$0.51−$0.52−$0.49
Surprise−16.2%+5.4%−9.6%+2.0%−9.5%+2.0%−1.0%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$15.3M$12.3M$13.6M$14.7M$16.0M$14.8M$15.7MPending
Estimate$15.2M$13.3M$14.4M$15.8M$15.8M$14.5M$15.5M$13.9M
Surprise+0.8%−7.3%−5.6%−6.7%+1.6%+1.9%+1.0%

History

DateEstimateReportedSurprise
Nov 2026−$0.49
Aug 2026−$0.52−$0.53−1.0%
May 2026−$0.51−$0.50+2.0%
Feb 2026−$0.42−$0.46−9.5%
Nov 2025−$0.50−$0.49+2.0%

The latest year is open to everyone — the 22 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Oct 2024
Jul 2024
Apr 2024
Jan 2024
Oct 2023
Jul 2023
Apr 2023
Jan 2023
Nov 2022
Jul 2022
Apr 2022
Feb 2022
Nov 2021
Aug 2021
Aug 2021
Dec 2020
Sep 2020
Jun 2020
Mar 2020
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 4, 2026−$0.49$13.9M
Aug 6, 2026−$0.52−$0.53−1.0%$15.5M$15.7M+1.0%−59.8%
May 11, 2026−$0.51−$0.50+2.0%$14.5M$14.8M+1.9%−23.8%
Feb 12, 2026−$0.42−$0.46−9.5%$15.8M$16.0M+1.6%−13.0%
Nov 5, 2025−$0.50−$0.49+2.0%$15.8M$14.7M−6.7%+2.7%

The latest year is open to everyone — the 22 quarters behind it read with an account.

Sign in
Aug 4, 2025
May 8, 2025
Feb 4, 2025
Oct 29, 2024
Jul 29, 2024
Apr 30, 2024
Jan 25, 2024
Oct 26, 2023
Jul 25, 2023
Apr 27, 2023
Jan 26, 2023
Nov 1, 2022
Jul 28, 2022
Apr 25, 2022
Feb 15, 2022
Nov 4, 2021
Aug 9, 2021
Aug 4, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020